This Article Full Text (PDF) All Versions of this Article: 1352458509104594v1 15/7/795    most recent References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Al-Izki, S Articles by Baker, D PubMed PubMed Citation Articles by Al-Izki, S Articles by Baker, D Social Bookmarking                         What's this?

Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography

Neuroscience Centre, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UKs.al-izki{at}qmul.ac.uk

G Pryce

Neuroscience Centre, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK

G Giovannoni

Neuroscience Centre, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK

D Baker

Neuroscience Centre, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK

Background

In multiple sclerosis (MS), demyelinating and neurodegenerative lesions develop throughout the central nervous system, which result in a loss of neurotransmission. As a result, people with MS exhibit a wide range of symptoms including dysfunction of the bladder, which can lead to urinary incontinence or retention. Such signs can develop in animal models of MS. Current assessments of bladder properties in animal models are generally invasive, electrophysiological techniques.

Objective

The use of a non-invasive, ultrasound system for measuring bladder volume in a mouse model of MS.

Methods

Chronic relapsing experimental autoimmune encephalomyelitis was induced in mice. The bladder volume was assessed using ultrasonography, during the disease course and following therapy with bethanechol chloride.

Results

It was demonstrated that volumes obtained ultrasonically positively-correlated (r = 0.960) with the urine volumes obtained by manual expression. It was also shown for the first time that bladder size increased significantly in mice with residual neurological deficit. Indeed, this increase in bladder size showed a strong, positive-correlation (r = 0.951) with the hind limb spasticity. Following treatment with bethanechol chloride, bladder volume significantly decreased in mice with chronic experimental autoimmune encephalomyelitis.

Conclusion

This study demonstrates a novel outcome measure in experimental MS that allows; repeated, non-invasive, high resolution ultrasonic monitoring of bladder function.

Key Words: bladder • experimental autoimmune encephalomyelitis • multiple sclerosis • spasticity • therapy • ultrasound

This version was published on July 1, 2009

Multiple Sclerosis, Vol. 15, No. 7, 795-801 (2009)
DOI: 10.1177/1352458509104594


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?